Skip to main content

Table 3 Acquisition SARS-CoV-2 spike variants over time in case 1, as detected by whole genome sequencing

From: Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy

Day

Variant(s)

29

A1841G; p.D614G

C2168T;p.T723I

  

79

A1841G; p.D614G

C2168T;p.T723I

  

150

A1841G; p.D614G

C2168T;p.T723I

419_427del; p.L141_V143del

G2306C; p.G769A

  1. CP was administered at day 54 and REG-COV2 at day 207